NRSN
Neurosense Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.99
−6.57%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$0.79
- Revenue estimate
- $535.6K
Latest reported
- Last report date
- Sep 25, 2026
- EPS actual
- -$2.06
- EPS estimate
- -$3.90
- Revenue actual
- —
- Revenue estimate
- $535.6K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +40.9%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 25, 2026 | -$3.90 | -$2.06 | Beat 47.18% | — |
| Dec 17, 2025 | — | -$0.11 | — | — |
| May 28, 2025 | -$0.10 | -$0.11 | Miss -4.80% | — |
| Dec 18, 2024 | -$0.16 | -$0.11 | Beat 31.25% | — |
| Sep 30, 2024 | -$0.20 | -$0.02 | Beat 90.00% | — |
| Apr 5, 2024 | -$0.20 | -$0.16 | Beat 20.00% | — |
| Mar 22, 2024 | -$0.20 | -$0.16 | Beat 20.00% | — |
| Nov 28, 2023 | -$0.24 | $0.10 | Beat 141.67% | — |
| Aug 16, 2023 | -$0.28 | -$0.44 | Miss -57.14% | — |
| Jun 1, 2023 | -$0.29 | -$0.33 | Miss -13.79% | — |
| Mar 22, 2023 | -$0.28 | -$0.27 | Beat 3.57% | — |
| Dec 1, 2022 | -$0.28 | -$0.25 | Beat 10.71% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026